Business
NANALYSIS SCIENTIFIC CORP. ANNOUNCES MARKETED PUBLIC OFFERING OF UP TO C$8 MILLION
NANALYSIS SCIENTIFIC CORP. ANNOUNCES MARKETED PUBLIC OFFERING OF UP TO C$8 MILLION ...
About this update from Nanalysis Scientific Corp
[{"type":"text","content":"\n \n \n \n NANALYSIS SCIENTIFIC CORP. ANNOUNCES MARKETED PUBLIC OFFERING OF UP TO C$8 MILLION\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n /NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN\n \n THE UNITED STATES\n \n /\n \n \n \n \n CALGARY, AB\n \n ,\n \n Jan. 20, 2022\n \n /CNW/ - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1)  (\"\n \n Nanalysis\n \n \", or the \"\n \n Company\n \n \") is pleased to announce that it has filed a preliminary short form prospectus with the securities commissions or similar regulatory authorities in each of the provinces of\n \n Canada\n \n , except for the Province of Québec (the \"\n \n Canadian Jurisdictions\n \n \"), in connection with a best efforts marketed public offering (the \"\n \n Offering\n \n \") of common shares  (the \"\n \n Common Shares\n \n \") of the Company at an offering price of\n \n $1.10\n \n per Common Share for gross proceeds of up to approximately\n \n $8,000,000\n \n .\n \n \n \n \n \n \n \n \n \n The Offering will be conducted by Echelon Wealth Partners Inc. (\"\n \n Echelon\n \n \") as lead agent and sole bookrunner,  and is subject to customary closing conditions, including the approval of the securities regulatory authorities and the TSX Venture.\n \n \n The Offering will be completed (i) by way of a short form prospectus to be filed in the Canadian Jurisdictions; and  (ii) on a private placement basis in\n \n the United States\n \n pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the \"\n \n U.S. Securities Act\n \n \"); and (iii) outside\n \n Canada\n \n and\n \n the United States\n \n on a basis which does not require the qualification or registration of any of the Company's securities under domestic or foreign securities laws.\n \n \n The Offering is expected to close on or about\n \n February 15, 2022\n \n , or such other date as the Company and Echelon may agree.\n \n \n The Company has granted Echelon an option t...